NAD sours on sweetener's probiotic claims
This article was originally published in The Tan Sheet
Executive Summary
Heartland Sweeteners should discontinue digestive and immunity health claims for its Nevella with Probiotics, according to the National Advertising Division, which finds Heartland lacks substantiation for the claims. Acting on a challenge by McNeil Nutritionals, maker of Splenda No Calorie Sweetener, the Council of Better Business Bureaus unit concluded in a report released Sept. 1 that the health claims inappropriately were based on studies of the GanedenBC30 probiotic ingredient rather than its finished product. NAD says Carmel, Ind.-based Heartland does not consider the amount of remaining live probiotic cells once Nevella is used in a hot beverage or baking - though GanedenBC30 is marketed for its heat-resistant properties (1"The Tan Sheet" Oct. 5, 2009). NAD adds the number of probiotic organisms in Nevella is "far below the minimum amount of cells tested and found to be efficacious in studies." Heartland disagrees with NAD but says it is revising its Nevella packaging
You may also be interested in...
New Products In Brief
Cepacol Fizzlers target kids' sore throats: Combe Inc. extends its benzocaine sore throat relief line into a grape-flavored pediatric product that rapidly dissolves on the tongue. Cepacol Fizzlers launched Sept. 1, the White Plains, N.Y., company said, and is labeled for use by patients ages 5 to 12. A box of 12 tablets retails for a suggested price of $5.99 at major food, drug and mass market stores
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.